HomeNGEN • CVE
add
NervGen Pharma Corp
Previous close
$2.02
Day range
$2.04 - $2.10
Year range
$1.50 - $3.98
Market cap
144.97M CAD
Avg Volume
129.18K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 4.87M | -28.15% |
Net income | -8.61M | -44.92% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -4.86M | 28.01% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 11.66M | -48.07% |
Total assets | 13.24M | -44.56% |
Total liabilities | 15.25M | 46.39% |
Total equity | -2.01M | — |
Shares outstanding | 69.93M | — |
Price to book | -67.33 | — |
Return on assets | -82.35% | — |
Return on capital | -693.50% | — |
Cash Flow
Net change in cash
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -8.61M | -44.92% |
Cash from operations | -3.09M | 38.93% |
Cash from investing | 1.00 | — |
Cash from financing | 74.77K | -6.16% |
Net change in cash | -3.13M | 40.43% |
Free cash flow | 2.36M | 159.27% |
About
Founded
2017
Headquarters
Website
Employees
10